A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality.
暂无分享，去创建一个
F. Saad | A. Briganti | S. Shariat | P. Karakiewicz | A. Kapoor | A. Antonelli | C. Simeone | P. Perrotte | E. Mazzone | S. Knipper | F. Mistretta | C. Palumbo | J. Lattouf